Kristen Bautz is named as a lobbyist on federal disclosure filings for 47 clients through H&m Strategies LLP and 1 other registrant. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code and Science/Technology.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| ZIMA INTERNATIONAL INC. D/B/A "DANDY" | H&M STRATEGIES LLP | Q3 2026 | Veterans, Health Issues |
| DROPBOX | H&M STRATEGIES LLP | Q3 2026 | Trade (domestic/foreign), Computer Industry, Copyright/Patent/Trademark |
| CHARTER BROKERAGE | H&M STRATEGIES LLP | Q3 2026 | Trade (domestic/foreign) |
| BOOKING HOLDINGS | H&M STRATEGIES LLP | Q3 2026 | Taxation/Internal Revenue Code, Travel/Tourism, Computer Industry |
| SYNOPSYS | H&M STRATEGIES LLP | Q3 2026 | Taxation/Internal Revenue Code, Trade (domestic/foreign) |
| RENEWABLE FUELS ASSOCIATION | H&M STRATEGIES LLP | Q3 2026 | Agriculture, Fuel/Gas/Oil |
| SPOTIFY | H&M STRATEGIES LLP | Q3 2026 | Media (information/publishing), Computer Industry, Copyright/Patent/Trademark |
| ETSY, INC. | H&M STRATEGIES LLP | Q3 2026 | Taxation/Internal Revenue Code, Consumer Issues/Safety/Products, Computer Industry |
| CARDIAC PET ALLIANCE | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| VERASTEM ONCOLOGY | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| AGILIX HEALTH | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| AGILENT TECHNOLOGIES, INC. | FARRAGUT PARTNERS LLP | Q3 2026 | Taxation/Internal Revenue Code, Trade (domestic/foreign), Tariff (miscellaneous tariff bills) |
| TAKEDA PHARMACEUTICALS AMERICA INC | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| PACT COALITION | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| UNIQURE INC. | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| BRIDGEBIO | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| PHARMACOSMOS THERAPEUTICS INC. | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| CYTOKINETICS INC. | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| DEXCOM, INC. | FARRAGUT PARTNERS LLP | Q3 2026 | Medicare/Medicaid |
| ORGANIZE ACTION NETWORK | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| ELISABETH POTTER MD PLLC | FARRAGUT PARTNERS LLP | Q3 2026 | Medicare/Medicaid |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| LANTHEUS MEDICAL IMAGING, INC. | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| U.S. WOMEN'S HEALTH ALLIANCE | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| SPR THERAPEUTICS | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| ONEONCOLOGY LLC | FARRAGUT PARTNERS LLP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| DAIICHI SANKYO INC | FARRAGUT PARTNERS LLP | Q3 2026 | Health Issues |
| GILEAD SCIENCES INC. | FARRAGUT PARTNERS LLP | Q3 2026 | Medicare/Medicaid, Health Issues |
| EDWARDS LIFESCIENCES, LLC | FARRAGUT PARTNERS LLP | Q3 2026 | Medicare/Medicaid, Health Issues |
| HERON THERAPEUTICS, INC. | FARRAGUT PARTNERS LLP | Q3 2026 | Medicare/Medicaid, Health Issues |
| COMMUNITY ONCOLOGY ALLIANCE | FARRAGUT PARTNERS LLP | Q3 2026 | Medicare/Medicaid, Pharmacy, Health Issues |
| GENENTECH | FARRAGUT PARTNERS LLP | Q3 2026 | Medicare/Medicaid, Health Issues |
| JOHNSON & JOHNSON SERVICES INC | FARRAGUT PARTNERS LLP | Q3 2026 | Medicare/Medicaid, Health Issues |
| INTEL CORP | H&M STRATEGIES LLP | Q3 2026 | Science/Technology, Taxation/Internal Revenue Code, Manufacturing |
| ANTI-DEFAMATION LEAGUE (ADL) | H&M STRATEGIES LLP | Q3 2026 | Civil Rights/Civil Liberties |
| FAMILIES AGAINST MANDATORY MINIMUMS (FAMM) | H&M STRATEGIES LLP | Q3 2026 | Law Enforcement/Crime/Criminal Justice |
| TOYOTA | H&M STRATEGIES LLP | Q3 2026 | Trade (domestic/foreign), Automotive Industry, Taxation/Internal Revenue Code |
| AMERICAN INSTITUTE OF ARCHITECTS | FARRAGUT PARTNERS LLP | Q3 2026 | Government Issues |
| SILICON VALLEY TAX DIRECTORS GROUP | H&M STRATEGIES LLP | Q3 2026 | Taxation/Internal Revenue Code |
| AURORA INNOVATION, INC. | H&M STRATEGIES LLP | Q3 2026 | Transportation, Science/Technology |
| YAHOO INC, AND VAR. SUBS/AFFILIATES (FKA COLLEGE PARENT, L.P. DBA "YAHOO") | H&M STRATEGIES LLP | Q3 2026 | Media (information/publishing), Consumer Issues/Safety/Products, Computer Industry |
| SILFAB SOLAR | FARRAGUT PARTNERS LLP | Q3 2026 | Tariff (miscellaneous tariff bills) |
| REPLIMUNE | FARRAGUT PARTNERS LLP | Q1 2026 | Health Issues |
| SIEMENS HEALTHINEERS | FARRAGUT PARTNERS LLP | Q2 2026 | Health Issues |
| CARDIOVASCULAR ASSOCIATES OF AMERICA | FARRAGUT PARTNERS LLP | Q2 2026 | Health Issues |
| NATIONAL ASSOCIATION OF HOME BUILDERS | H&M STRATEGIES LLP | Q3 2025 | Manufacturing, Housing |
| CONSUMER TECHNOLOGY ASSOCIATION | H&M STRATEGIES LLP | Q2 2025 | Communications/Broadcasting/Radio/TV |
| CHARTER BROKERAGE | FARRAGUT PARTNERS LLP | Q2 2025 | Trade (domestic/foreign) |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 41 | 2 |
| 2025 | 34 | 2 |
| Year | Items | Total |
|---|---|---|
| 2026 | 7 | $4K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Kristen Bautz. See the Capitol Clarity rankings and method.